Pharmaceutical company Eli Lilly has launched a public-private R&D funding programme in the US and Europe, PMLiVE reports.
The programme consists of two components, the news website says.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.